Ballentine Partners »

Krystal Biotech shares owned by Ballentine Partners

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Ballentine Partners from 13F filings

Historical chart of Ballentine Partners investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Ballentine Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Ballentine Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $370k 2.1k 177.93
2023-12-31 $258k 2.1k 124.06
2023-09-30 $241k 2.1k 116.00
2023-06-30 $244k 2.1k 117.40

More positions owned by Ballentine Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Core Msci Emkt (IEMG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Index Fds Large Cap Etf (VV)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Etf (IWB)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Ballentine Partners

Top funds holding Krystal Biotech

venBio Select Advisor
Vanguard Group
Redmile Group
Frazier Life Sciences Management
Jennison Associates
Lord, Abbett & Co
Dimensional Fund Advisors
Ikarian Capital
Credit Suisse
T. Rowe Price Associates
Balyasny Asset Management
TimesSquare Capital Management
First Turn Management
Goldman Sachs Group
Jpmorgan Chase & Co

View all funds holding Krystal Biotech